🟢 Citius Pharmaceuticals is trading 5% up today as LYMPHIR adoption strengthens

Citius Pharmaceuticals is trading at $0.71 (+5.20%) as stronger LYMPHIR commercial adoption drives the move.

• New ordering institutions increased 78% quarter over quarter to 42 sites, while vial orders rose 31% for the quarter ended June 30, 2026.
• The company-specific catalyst outweighs cautious broader-market trading and healthcare-sector support on August 11, 2026.